95-0794: INFLUENZA VIRUS VACCINE.
The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include valence: TRIVALENT, unit_package_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-420-4960, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| valence | TRIVALENT |
| special_features | 0.5 ML DOSE; 10 DOSES; WHOLE OR SPLIT VIRUS; 1996-1997 INFLUENZA SEASON; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS OVER 12 YEARS OLD |
| unit_package_type | VIAL |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| NSN | 6505-01-420-4960 |
| UNIT PACKAGE TYPE | VIAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| VALENCE | TRIVALENT |
| SPECIAL FEATURES | 0.5 ML DOSE; 10 DOSES; WHOLE OR SPLIT VIRUS; 1996-1997 INFLUENZA SEASON; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS OVER 12 YEARS OLD |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
No substitute or cross-reference records for this part.